| Trial ID: | L0302 |
| Source ID: | NCT04194242
|
| Associated Drug: |
HEC96719
|
| Title: |
The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Steatohepatitis (NASH)
|
| Interventions: |
Drug: HEC96719 tablets|Drug: Placebo tablet
|
| Outcome Measures: |
Adverse events of the single ascending-dose|Cmax|AUC|Tmax|T1/2
|
| Sponsor/Collaborators: |
Sunshine Lake Pharma Co., Ltd.
|
| Gender: |
All
|
| Age: |
18 Years to 45 Years ?? (Adult)
|
| Phases: |
Phase 1
|
| Enrollment: |
64
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
January 3, 2020
|
| Completion Date: |
July 17, 2020
|
| Results First Posted: |
--
|
| Last Update Posted: |
December 28, 2020
|
| Locations: |
The Shanghai xuhui district central hospital, Shanghai, Shanghai, China
|
| URL: |
https://ClinicalTrials.gov/show/NCT04194242
|
